Current research hotspot and future development trend of esketamine: A bibliometric analysis

Current research hotspot and future development trend of esketamine: A bibliometric analysis

Bibliographic Details
Main Authors:	Li Xian, Hong Li, Jinlong Yuan, Zhiyong Gao
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Asian Journal of Surgery
Subjects:	Esketamine Ketamine Bibliometric analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S101595842300725X

Similar Items

Global Trends and Hotspots in Esketamine Research: A Bibliometric Analysis of Past and Estimation of Future Trends
by: Li X, et al.
Published: (2022-04-01)

The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)

The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine
by: Jay Wang, et al.
Published: (2022-03-01)

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
by: Johanna Louise Keeler, et al.
Published: (2023-05-01)

Case report: Effectiveness of brexpiprazole and esketamine/ketamine combination: A novel therapeutic strategy in five cases of treatment-resistant depression
by: Lai Fong Chan, et al.
Published: (2022-07-01)

Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study
by: Wang J, et al.
Published: (2019-12-01)

Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
by: Giovanni Martinotti, et al.
Published: (2021-06-01)

Esketamine may be an ideal substitute for ketamine during cochlear function measurement
by: Yufeng Li, et al.
Published: (2021-08-01)

Esketamine, a new treatment for resistant depression: a systematic review of the literature
by: Mercedes Valtueña García, et al.
Published: (2021-07-01)

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis
by: Alexandros Matsingos, et al.
Published: (2024-03-01)

Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
by: Alessandro Rodolico, et al.
Published: (2024-02-01)

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
by: Ludivine Boudieu, et al.
Published: (2023-12-01)

Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
by: Hewa Artin, et al.
Published: (2022-06-01)

The cognitive effects of esketamine: what do we know so far?
by: M. Barbosa, et al.
Published: (2022-06-01)

The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
by: Marcatili Matteo, et al.
Published: (2021-09-01)

Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study (KetCRPS-2)
by: Thomas J. P. Mangnus, et al.
Published: (2023-03-01)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
by: Aleksander Kwaśny, et al.
Published: (2023-04-01)

A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study
by: Eduard Falk, et al.
Published: (2020-01-01)

Research advances in the clinical application of esketamine
by: Xiao‐Xi Zhang, et al.
Published: (2022-03-01)

Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
by: Matteo Marcatili, et al.
Published: (2022-09-01)

Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions
by: Anya Ragnhildstveit, et al.
Published: (2022-03-01)

Clinical efficacy and tolerability of Esketamine: a case series
by: C. Passani, et al.
Published: (2022-06-01)

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report
by: Boney Joseph, et al.
Published: (2023-08-01)

Toward Synergies of Ketamine and Psychotherapy
by: David S. Mathai, et al.
Published: (2022-03-01)

Effects of somatic treatments on suicidal ideation and completed suicides
by: Elise M Hawkins, et al.
Published: (2021-11-01)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01)

Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
by: Dominika Psiuk, et al.
Published: (2022-09-01)

Safety and efficacy of esketamine for postoperative analgesia in pediatric patients with hypospadias
by: Yong Xu, et al.
Published: (2023-04-01)

Effect of pretreatment with a small dose of esketamine on sufentanil-induced cough during anesthesia induction: a randomized controlled trial
by: Liangliang Gao, et al.
Published: (2024-03-01)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)

Treating with esketamine nasal, will increase blood pressure?
by: V. Rosello-Molina, et al.
Published: (2021-04-01)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
by: Maria Gałuszko-Węgielnik, et al.
Published: (2023-01-01)

Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling
by: Stephen M. Stahl, et al.
Published: (2022-10-01)

The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: A systematic review and meta-analysis
by: Mattia Marchi, et al.
Published: (2022-11-01)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
by: Lorena Catarina Del Sant, et al.
Published: (2022-12-01)

Effects of Different Doses of Esketamine on Pain Sensitivity of Patients Undergoing Thyroidectomy: A Randomized Controlled Trial
by: Yan-ling Ren, et al.
Published: (2023-03-01)

The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial
by: Li W, et al.
Published: (2023-09-01)

Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections
by: Matheus Ghossain Barbosa, et al.
Published: (2021-01-01)

A Bibliometric Analysis of Research on Ketamine From 2001 to 2020
by: Huihui Miao, et al.
Published: (2022-02-01)